Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
1.5K
Tumor Progression02:07

Tumor Progression

3.1K
3.1K
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The FLASH Effect in 3D and 2D Models: Preserving Tumor Control while Reducing Apoptosis in Normal Cells.

Radiation research·2026
Same author

Engineering iron oxide nanoparticles for enhanced radiosensitization.

RSC advances·2026
Same author

Volumetric postmortem MRI of the medial temporal lobe in Alzheimer's disease and related disorders: methodological advances and implications for in vivo biomarker development.

NeuroImage·2026
Same author

Slow and fast locomotor muscle adaptations to sustained intermittent hypoxaemia.

The journal of physiological sciences : JPS·2026
Same author

Localized delivery of hyaluronic acid-doxorubicin from a surgical paste for post-operative glioblastoma treatment.

Materials today. Bio·2026
Same author

Gold Nanoparticles Combine with Radiation Therapy to Drive Immunogenic Macrophage Reprogramming.

ACS applied bio materials·2026

Related Experiment Video

Updated: Apr 26, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.0K

A mitochondrial switch promotes tumor metastasis.

Paolo E Porporato1, Valéry L Payen1, Jhudit Pérez-Escuredo1

  • 1Institut de Recherche Expérimentale et Clinique (IREC), Pole of Pharmacology (FATH), Université catholique de Louvain (UCL), Brussels 1200, Belgium.

Cell Reports
|July 29, 2014
PubMed
Summary

Cancer metastasis involves mitochondrial changes, not just aerobic glycolysis. Increased mitochondrial superoxide production, from electron transport chain (ETC) overload or inhibition, drives cancer cell migration and metastasis. Scavenging superoxide with mitoTEMPO blocked metastasis.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.7K

Related Experiment Videos

Last Updated: Apr 26, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.0K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.7K

Area of Science:

  • Mitochondrial metabolism
  • Cancer biology
  • Metastasis research

Background:

  • Metastatic cancer progression is linked to poor patient outcomes.
  • Aerobic glycolysis is a known contributor to metastasis.
  • The role of mitochondrial metabolic shifts in metastasis requires further investigation.

Purpose of the Study:

  • To investigate metabolic alterations in cancer cells that promote metastasis.
  • To identify novel mitochondrial pathways involved in cancer cell migration and invasion.
  • To explore therapeutic strategies targeting mitochondrial dysfunction in metastatic cancer.

Main Methods:

  • Analysis of metabolic changes in metastatic cancer cells.
  • Investigating the role of the electron transport chain (ETC) and mitochondrial superoxide production.
  • Utilizing protein tyrosine kinases Src and Pyk2 as downstream effectors.
  • Employing mitoTEMPO to scavenge mitochondrial superoxide in preclinical models.

Main Results:

  • Identified a novel mitochondrial switch involving electron transport chain (ETC) overload, leading to increased mitochondrial superoxide production.
  • Demonstrated that both ETC overload and partial ETC inhibition enhance tumor cell migration, invasion, clonogenicity, and metastasis.
  • Showcased that Src and Pyk2 act as downstream mediators in these processes.
  • Confirmed that mitoTEMPO effectively blocks tumor cell migration and prevents spontaneous metastasis in murine and human models.

Conclusions:

  • Mitochondrial superoxide production, driven by ETC alterations, is a critical factor in promoting cancer metastasis.
  • Targeting mitochondrial superoxide production represents a promising therapeutic strategy for inhibiting metastatic progression.
  • The findings offer new insights into the metabolic underpinnings of cancer metastasis.